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Abstract 
Magnesium and its alloys may potentially be applied as degradable metallic 
materials in orthopaedic implantations due to their degradability and resemblance to 
human cortical bone. However, the high corrosion rate and accumulation of hydrogen 
gas upon degradation hinders its clinical application. In this study, we adopt a new 
approach to control the corrosion rate by coating a controllable polymeric membrane 
fabricated by polycaprolactone and dichloromethane onto magnesium alloys, in which 
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pore size was controlled during the manufacturing process. The addition of the 
polymeric membrane was found to reduce the degradation rate of magnesium, and the 
bulk mechanical properties were shown to be maintained upon degradation. The in-
vitro studies indicated good cytocompatibility of eGFP and SaOS-2 osteoblasts with 
the polymer-coated samples, which was not observed for the uncoated samples. The 
in-vivo study indicated that the uncoated sample degraded more rapidly than that of 
the polymer-coated samples. Although new bone formation was found on both 
samples, as determined by Micro-CT, higher volumes of new bone were observed on 
the polymer-coated samples. Histological analysis indicated no inflammation, 
necrosis or hydrogen gas accumulation on either of the samples during degradation. 
Collectively, these data suggest that the use of polymeric membrane may be 
potentially applied for future clinical use. 
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1. Introduction 
The most commonly used materials for bone fracture fixation are usually made of 
medical-grade metals such as 316L stainless steel, pure titanium and its alloys, and 
cobalt-chromium-based alloys [1, 2] which are non-biodegradable. However, one 
desirable characteristic of an implant is its ability to be degraded after the bone has 
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healed as problems may arise if the implants are not degradable. Long term adverse 
effects or even an increased risk of local inflammation may occur after long-term 
implantation since the metallic implant is a foreign body to human tissues [3]. If this 
is the case, second surgery is subsequently conducted for implant removal. However, 
repeated surgery not only increases the morbidity rate of the patients, but also results 
in an increase of health care costs and longer hospitalization [1]. To reduce such 
complications, the use of biodegradable metallic implants has been investigated [1, 4-
7].   
Magnesium and its alloys are the most commonly used metal amongst all the 
degradable metallic materials. However, the major obstacles of the clinical use of 
magnesium-based materials are its rapid degradation rate and the release of hydrogen 
gas upon degradation [8, 9]. Troitskii and Tsitrin used a magnesium-cadmium alloy to 
secure various fractures, however, reported that the mechanical integrity of the 
magnesium alloy was only maintained for 6-8 weeks with the release of hydrogen 
during the corrosion process [10]. Hence, in order to make use of magnesium-based 
materials feasible for surgical implantation, the corrosion rate must be controlled. 
The enhancement of the corrosion resistance of magnesium can be achieved by 
using different modification methods such as  alloying [11] and various surface 
treatments [12]. Witte et al. [4, 12] suggested that magnesium alloys, especially those 
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containing rare earth elements seemed to be suitable for use as orthopaedic implants. 
However, in addition to the alteration of its original mechanical properties, the 
addition of rare earth metals such as zirconium and cerium into the magnesium 
substrate may potentially add toxic effects to cells [13, 14], as the cytocompatibility 
of these elements is not known. In the studies by Li et al. (2008) [5], Zhang et al. 
(2009) [15] and Zberg et al. (2009) [16]; a magnesium-calcium alloy, magnesium-zinc 
alloy and magnesium-zinc-calcium alloys, were fabricated respectively and used as 
biodegradable implants, however, the change in mechanical properties of these alloys 
during degradation were not addressed.  
Apart from alloying, surface modifications such as micro-arc oxidation (MAO), 
ion implantation and plasma anodisation to improve the corrosion properties of 
magnesium alloys have been investigated [17-22]. Electrochemical tests were 
conducted with those surface-treated samples, and an increase in corrosion resistance 
was reported [17-22], however, as the biological integrity of those surface-treated 
samples was not reported, there was insufficient data to draw any conclusion before 
applying in clinical use.    
In this paper, we improve the properties of magnesium implants via the deposition 
of a biodegradable polymer-based porous membrane made of polycaprolactone (PCL) 
and dichloromethane (DCM) onto a commercially available magnesium alloy in order 
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to control its degradation rate. This paper aims at investigating the feasibility of these 
polymeric membranes in controlling the degradation of magnesium alloy under in-
vitro and in-vivo conditions, and addresses the cytocompatibility and mechanical 
integrity of the deposited samples during degradation.  
 
2. Materials and methods 
2.1  Sample preparation 
An AZ91 magnesium ingot with 9 wt% aluminium and 1 wt% zinc (Jiaozuo City 
Anxin Magnesium Alloys Scientific Technology Co., Ltd.) was used in this study. 
Disc samples which were 5 mm in diameter and 4 mm in thickness were prepared for 
the electrochemical corrosion test, immersion test and in-vitro studies while rod 
samples were prepared for the mechanical integrity testing and in-vivo animal study. 
The rod samples for mechanical testing were 3 mm in diameter and 9 mm in length 
whereas for the in-vivo animal study, were 3 mm in diameter and 6 mm in length. All 
the samples were ground and then polished to remove the oxide. Afterwards, they 
were ultrasonically cleaned with ethanol before conducting the deposition process.  
The deposit material was prepared by mixing polycaprolactone (PCL) (Sigma-
Aldrich, USA) with the average molecular weight Mn ~ 80,000 g/mol and 
dichloromethane (DCM) (Fisher chemicals, England). Two different concentrations of 
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deposit material containing either 3.33% (w/v) PCL or 2.5% (w/v) PCL in solvent 
were applied in order to fabricate various porous sizes and porosities. After the 
mixture was prepared, the polymer-based membrane was deposited layer by layer on 
the sample surface by a custom designed spraying device. The device was equipped 
with air flow and temperature control, thereby standardizing the thickness, 
homogeneity and adhesiveness of the polymer-based membrane. The air-flow 
pressure and spraying temperature were 276 kPa and 37℃, respectively. The spraying 
process was confined at the conditions of 50% humidity, 22℃ and atmospheric 
pressure.  
 
2.2  Characterization of the polymer-based membrane 
2.2.1 Surface morphology analysis 
Scanning electron microscopy (SEM) was employed to visualize the surface 
morphology of low porosity membrane (LMP) and high porosity membrane (HPM) 
after depositing the polymer on the magnesium alloy surface. The average pore size 
and the total pore area were analyzed using CTAn program (Skyscan Company, 
Belgium). 
 
2.2.2 Analysis of the thermal properties of the polymer-based membranes 
 
 
7 
 
The thermal properties, including the transition temperatures such as the melting 
and crystallization temperatures and the crystallinity of the polymer-based membranes 
were determined by differential scanning calorimetry (DSC, TA Analysis, 2910 
MDSC V4.4E). For the DSC measurement, the weight of the samples ranged from 5 
to 10 mg and the melting curves were recorded from -20℃ to +80℃ with a heating 
rate of 10℃/min. The melting point of PCL is approximately 60℃ and therefore, 80
℃ was chosen as the upper heating temperature in order to obtain complete melting 
of PCL membrane. Two cycles of heating and cooling were conducted, where the first 
cycle was used to eliminate the heat history of the polymer membrane [23]. All of the 
samples were firstly heated from -20℃ to 80℃, and then maintained at 80℃ for one 
minute to ensure the complete melting of the PCL crystals. The samples were 
subsequently quenched to -20℃ at the rate of 10℃/min and then heated again from -
20℃ to 80℃ at a rate of 10℃/min. The data was obtained from the second cycle. 
 
2.3  Electrochemical corrosion analysis 
An electrochemical test was conducted to evaluate the corrosion resistance of the 
polymer-deposited and untreated magnesium alloys. The samples were embedded in 
epoxy resin and the top surface was exposed for testing. The corrosion testing was 
conducted in a standard simulated body fluid (SBF) at a pH of 7.4, and resistance was 
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characterized by using potentiostat (VersaStat II EG&G), and the corrosion medium 
was a standard simulated body fluid (SBF) at a pH of 7.4. The temperature was 
controlled at 37+0.5oC throughout testing. Prior to polarization, the samples were 
immersed in 500ml SBF for 15 minutes. The polarization scan started from -220mV 
at a scan rate of 1mV/s, and the changes in the free corrosion potential (Ecorr) were 
monitored as a function of time. 
 
2.4  Immersion test 
The immersion test was carried out at different time points to monitor the 
degradation and the release of magnesium ions of the polymer-deposited and 
untreated samples. Five of each of the polymer-deposited and untreated samples were 
individually immersed into sealable capsules containing 10ml SBF and then incubated 
at 37℃ for a total of 2 months. The release of magnesium ions from the samples was 
measured at 9 different time points (i.e. 6 and 12 hours, and 1, 2, 4, 7, 14, 30, and 60 
days) using inductively-coupled plasma mass spectrometry (ICPMS) (Optical Emission 
Spectrometer, Perkin Elmer, Optima 2100DV). The correlation between ion dissolution 
and time was subsequently established. In addition, the pH values of the samples were 
also measured, and the rate of corrosion was determined by measuring the weight lost 
from each of the samples.  
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The magnesium hydroxide composites formed on the sample surface during 
corrosion were removed by immersing the samples into chromic acid (200 g/l CrO3 + 
10 g/l AgNO3) for 5 minutes [24, 25]. Afterwards, the deposited samples were rinsed 
with running distilled water, and then dried under vacuum. The difference in weight 
before and after chromic acid immersion indicated the amount of magnesium 
hydroxide formation, and thus the amount of magnesium ions released from the 
sample. 
 
2.5 In-vitro studies  
2.5.1 Cell viability test of the extracts from the immersion test 
The MTT assay was used to determine the cytotoxicity of the polymer-deposited 
samples to mammalian cells. The test was carried out by using an indirect method, 
where the immersion extracts collected from the immersion test were used for 
culturing cells. 7 × 104 cells/cm2 SaOS-2 human osteoblasts were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) (Invitrogen) supplemented with 10% 
(v/v) fetal bovine serum (Biowest, France), antibiotics (100 U/ml of penicillin and 
100 µg/ml of streptomycin), and 2 mM L-glutamine in a 96-well tissue culture plate 
and incubated at 37℃ in an atmosphere of 5% CO2 and 95% air for one day. On the 
second day, the culture media in each well were replaced with immersion SBF 
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extracts supplemented with 10% fetal bovine serum (FBS, Biowest, France), and 
incubated at 37℃ in an atmosphere of 5% CO2 and 95% for three days. 10µL of MTT 
solution [5mg thiazolyl blue tetrazolium bromide powder in 1ml phosphate buffered 
saline (PBS, OXOID Limited, England)] was then added into each well on the third 
day. The 96-well tissue culture plate containing MTT solution and cells were then 
incubated at 37℃ in an atmosphere of 5% CO2 and 95% air for a further three days. 
After incubation, 100µl of 10% sodium dodecyl sulphate (SDS, Sigma, USA) in 
0.01M hydrochloric acid was added into each well and incubated at 37℃ in an 
atmosphere of 5% CO2 and 95% air for 18 hours. The absorbance was recorded by the 
multimode detector (Beckman Coulter DTX 880) at 570nm wavelength, with a 
reference wavelength of 640nm to determine the cell viability in comparison to the 
control.  
 
2.5.2   Determination of cell compatibility of the polymer-coated magnesium alloy 
To evaluate the cyto-compatibility of the polymer-deposited magnesium alloys, 
standard cell culturing was applied to the coated and uncoated sample surfaces. Six of 
each of the coated and uncoated AZ91 magnesium alloy was fixed to the bottom of a 
96-well tissue culture plate. A cell suspension consisting of 1.7 × 104 cells/cm2 
enhanced Green Fluorescent Protein Osteoblasts (eGFPOB) was seeded onto the 
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surface of the uncoated and coated sample surfaces, and into wells without any 
samples which served as a control for normal culturing conditions. Cells were grown 
in a volume of 100μl DMEM medium and incubated at 37℃ in an atmosphere of 5% 
CO2 and 95% air. Cell attachment and proliferation were examined after 1 and 3 days 
of culture, where triplicate samples were examined at each time point. Cells were 
allowed to reach confluence during the examination period. Cell morphology was 
observed by using a fluorescent microscope (Niko ECL IPSE 80i, Japan). The 
attached living eGFP-expressive osteoblasts were visualized using a 450-490 nm 
incident filter, and the fluorescence images were emitted at 510 nm and captured 
using a Sony DKS-ST5 digital camera.  
 
2.6  Mechanical testing 
Compression testing was used to determine and compare the bulk mechanical 
properties, including yield strength and Young’s modulus, of the polymer-coated and 
uncoated samples during degradation.  
The samples were immersed into SBF using the same protocol as described for the 
immersion test, and the mechanical properties were monitored at 9 different time 
intervals (i.e. 6 and 12 hours, and 1, 2, 4, 7, 14, 30, and 60 days). The testing speed 
was set at a rate equivalent to 0.45 m/m.min and a Material Testing System (MTS) 
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858.02 Mini Bionix (USA) testing machine was used to conduct the compression 
testing. 
 
2.7  In-vivo animal study 
2.7.1 Surgery 
The anaesthetic, surgical and post-operative care protocols were examined by 
and fulfilled the requirements of the University Ethics Committee of The University 
of Hong Kong, and the Licensing Office of the Department of Health of the Hong 
Kong Government.  
Three six-month old female New Zealand White rabbits from the Laboratory 
Animal Unit of The University of Hong Kong were used in this study. Their average 
weights were approximately 4.5-5.0 kg and the chosen operation site was the greater 
trochanter. Each rabbit was implanted with either of HPM-coated, LPM-coated or 
uncoated samples, where two samples were implanted into each rabbit. Both uncoated 
and HPM samples were implanted into the right greater trochanter while LPM 
samples were implanted into the left greater trochanter (as-shown in Figure 1). In 
order to monitor the in-vivo degradation of the coated and uncoated samples, serial 
time points of 1 week and 1 and 2 months were set.  
Rabbits were anaesthetized with Ketamine (35mg/kg), Xylazine (5mg/kg) and 
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Acepromazine (1mg/kg) by subcutaneous administration.  The operation sites of the 
rabbits were shaved. After anaesthesia, decortication was carried out. Two holes 3 mm 
in diameter were made at the greater trochanter through a minimal invasive approach. 
A hand driller was used to drill a hole 6mm in depth. Subsequently, the magnesium 
rods were implanted into the prepared holes on either the left or right leg of the rabbits. 
The wound was then sutured layer by layer, and a proper dressing was applied over 
the incision. After the operation, all rabbits received subcutaneous injections of 1 
mg/kg terramycin (antibiotics) and 0.5 mg/kg ketoprofen. The rabbits were sacrificed 
2 months post-operatively.  
 
2.7.2 Radiographic evaluation 
At each particular time point (i.e. 1 week, 1 and 2 months), x-ray radiography 
(Faxitron x-ray corporation) was conducted at the operation site so as to monitor the 
healing process immediately after the surgery and prior to sacrificing the rabbits.  
 
2.7.3 Analysis of the magnesium ion concentration in blood of implanted rabbits 
Blood was collected prior to, 1 week, 1 month, and 2 months after the operation 
to determine the magnesium ion concentrations in the blood. Blood was centrifuged at 
1,339 g for 15 mins at room temperature (2-5 Sartorius, Sigma, USA) and the sera 
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were collected and stored at 4℃ till analysis. Prior to analysis, the sera were diluted 
10 times in double distilled water. The magnesium ion concentration was determined 
using inductively-coupled plasma mass spectrometry (ICPMS) (Optical Emission 
Spectrometer, Perkin Elmer, Optima 2100DV), and the concentrations of magnesium 
ions released from both treated and untreated samples were compared.  
 
2.7.4 Histological evaluation 
The bone samples with implants were harvested and fixed in 10% buffered 
formalin for 3 days. Subsequently, a standard tissue processing step was conducted to 
change the samples from an aqueous stage to an organic stage. A dehydrating process 
was performed using 70%, followed by 95% then 100% ethanol. The samples were 
immersed in each of the solutions for 3 days. Xylene was subsequently used as a 
transition between ethanol and methyl-methacrylate, where the samples were 
immersed in xylene for 3 days. Finally, all the samples were embedded in methyl-
methacrylate (Technovit 9100 New®, Heraeus Kulzer, Hanau, Germany) as per 
manufacturer’s instructions. Prior to cutting the samples, the whole embedded 
samples were scanned in a micro-computed tomography device (SKYSCAN 1076, 
Skyscan Company) to view the extent of corrosion of the samples. After scanning, 2D 
planes were reconstructed using the NRecon (Skyscan Company) and the 3D models 
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were generated by CTVol (Skyscan Company). The residual implant volume was then 
analyzed using CTAn program (Skyscan Company) which is used to examine micro-
CT datasets for morphometry and densitometry, as well as new bone growth. After 
analyzing by micro-CT, the embedded samples were then cut into sections with a 
thickness of 200μm and then micro-grounded down to 50 – 70μm thickness. The 
sectioned samples were stained with gimesa (MERCK, Germany) stain. The 
morphological and histological analyses were performed and viewed under a light 
microscope to observe for any bone on-growth and integration with the host tissue.  
 
3. Results 
3.1 Characterization of the polymer membrane 
3.1.1 Surface morphology analysis 
Figure 2 shows the surface morphologies of the polymer-deposited samples 
under scanning electron microscopy (SEM). The total pore area of the LPM sample 
was found to be approximately 236 µm2 in which most of the pores were between 0.8 
µm and 1.6 µm in size. The average pore size was 0.302 µm, and the porosity of the 
LPM sample was 18.2%. On the other hand, the total pore area of the HPM sample 
was approximately 572.1 µm2, with the pore size ranging between 3.2 µm and 6.4 µm. 
The average pore size 0.995 µm, and the porosity of the HPM sample was 44.1% (as 
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shown in Figure 3).  
 
3.1.2 Analysis of the thermal properties of the polymer-based membranes 
Differential scanning calorimetry (DSC) was used to study the thermal properties 
of the polymer membranes. Figure 4 shows the heating and cooling thermograms of 
different PCL membranes, respectively. The melting temperature (Tm) and the change 
of melting of heat (△Hm) were obtained from the heating thermograms while the 
crystallization temperature (Tc) was identified from the cooling thermograms. The 
crystallinity degree Xc% of the polymer membrane could be determined by using the 
reference of 136 J/g for crystalline polycaprolactone [26, 27]. Pure PCL had the 
highest melting temperature of 61.24°C and the lowest crystallization temperature of 
18.15°C as compared to the polymer-coated samples. The melting temperatures were 
decreased from pure PCL towards HMP in which HPM was having the melting 
temperature of 56.2°C whereas the crystallization temperatures were increased from 
pure PCL to HPM where it had the crystallization temperature of 29.03°C. The 
highest crystallinity was found on the HPM of 41.3% whereas the lowest crystallinity 
was found on the PCL only of 35.9%. LPM had approximately 2% lower crystallinity 
as compared to the HPM. The data obtained from the DSC thermograms are 
summarized in Table 1. 
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3.2 Electrochemical measurement 
The electrochemical polarization curves of the PCL samples are shown in Figure 
5. The corrosion potential (Ecorr) showed that the polymer-coated magnesium alloys 
shifted the open circuit potential to a more positive potential. The Ecorr, with reference 
to the AZ91 uncoated magnesium alloy, increased by 1444 mV in LPM samples and 
1114 mV in HPM samples. At the same time, the values of the corrosion current (Icorr) 
of the polymer-coated samples, especially LPM sample, were lower than that of the 
uncoated sample. Therefore, both the Ecorr and Icorr showed that the PCL-coated 
samples were able to enhance the corrosion resistance of magnesium alloy.  
 
3.3 Immersion test 
Figures 6 and 7 show the concentration of the magnesium ions released and the 
pH values of the polymer-coated and uncoated magnesium alloys, respectively. The 
magnesium ion concentrations as determined by inductively coupled plasma mass 
spectrometry (ICPMS) of the uncoated samples was found to increase from 
approximately 19 ppm after 6 hours of immersion, to 1,360 ppm after 60 days of 
immersion, while the coated samples had a very slow release rate by comparison. The 
magnesium ion concentrations that were detected between 6 hours and 60 days of 
immersion for the LPM and HPM samples ranged between 2.6 ppm to 238.6 ppm and 
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from 2.4 ppm to 433.4 ppm, respectively. The results revealed that the amount of 
magnesium leached from all the coated samples were significantly (p<0.05) reduced 
compared to the uncoated sample. The pH range of LPM and HPM samples was 
found to be between 7.17 to 7.62, and 7.19 to 7.86, respectively, after 2 months of 
immersion, while the uncoated sample had the pH values ranging between 7.52 and 
8.20.  
Figure 8 shows the degradation rate of the PCL-coated and uncoated samples in 
terms of the amount of weight lost from the samples. The total weight lost from the 
uncoated sample was approximately 17 mg after 2 months of immersion, however, for 
the polymer-coated samples, the total weight lost from the LPM and HPM samples 
after 2 months were 3.59 mg and 6.22 mg, respectively.  
 
3.4  In-vitro studies 
3.4.1 Cell viability test of the extracts from the immersion test  
Figure 9 shows the SaOS-2 human cell viability which grown in the extracts 
from the immersion test, as determined by the MTT assay. All the extracts of the 
polymer-coated samples (LPM and HPM) were well tolerated by the osteoblasts with 
the cell viability ranging from 130% to 80% until day 60, while the uncoated samples 
ranged from 130% to 20%. A sudden drop in the cell viability of the uncoated samples 
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was observed after day 4, whereas the cell viability of the polymer-coated samples 
remained at approximately 100%. The correlation between cell viability and the 
amount of magnesium ions released is shown in Figures 10a and 10b. The highest 
amount of magnesium ions released from the HPM sample at day 60 was 443 ppm 
with a cell viability of 80%, whereas the highest amount of magnesium ions released 
from the LPM sample was 240 ppm with a cell viability of approximately 96%. 
However, for the uncoated samples, the amount of magnesium ions released at day 60 
was 1,360 ppm which was associated with a cell viability of 25%.  
 
3.4.2 Determination of cell attachment and growth of the polymer-coated magnesium 
alloy 
Figure 11 shows that viable cells were observed on the uncoated and polymer-
coated samples after 1 and 3 days of cell culturing. On day 1 focal adhesion and cells 
spreading were observed on the polymer-coated samples (Figure 11a), while no cell 
attachment was observed on the uncoated sample. After 3 days of cell culture (Figure 
11b), the osteoblasts exhibited good cell spreading and had almost grown to 100% 
confluency on the polymer-coated samples, in contrast to the uncoated sample which 
had no cell growth.  
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3.5 Mechanical characterization 
Figure 12 shows the results of the compression test. The compressive strengths 
of both coated and uncoated samples were found to be similar before immersion (i.e. 
time point 0). Subsequently, the strength of the uncoated samples decreased as the 
immersion period increased, while the strength of the polymer-coated samples kept 
constant between the 6 hours and 60 days time points. The compressive strengths of 
LPM and HPM samples remained at approximately 170MPa after 60 days of 
immersion, however, that of the uncoated sample has dropped to 111MPa. Therefore, 
the polymer-coated samples were able to maintain a constant compressive strength for 
a period of time.    
 
3.6 In-vivo animal study 
3.6.1 Radiographic evaluation 
Figure 13 shows the radiographs of the rabbit greater trochanter after 1 week, 1 
and 2 months post-operation. No gas bubbles were observed after implantation, and 
all the implants were intact throughout the whole implantation period. However, the 
radiographs of the whole implants were not clear under x-ray radiography, therefore 
other evaluation method including the Micro-computed tomography analysis was 
adopted to observe the degradation rate of the implant.  
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3.6.2 Micro-computed tomography analysis 
The in-vivo corrosion morphology of the implant in the greater trochanter in the 
New Zealand White rabbits was studied using micro-computed tomography. Figure 14 
shows the cross sections and 3D models of the implants. The whole implant could be 
visualized after conducting the reconstructions. Corrosion (red arrows in Figures 14 d, 
f, g and i) was observed on both uncoated and HPM but not on LPM samples. 
Moreover, all the samples showed direct contact with the newly formed bone, where 
the PCL membrane was clearly seen on the LPM and HPM samples (yellow arrows in 
Figures 14 e and f). Figure 15 shows the 3D models of the newly formed bone on both 
coated and uncoated implants, and Table 2 shows the values of the newly formed bone 
volume around the implants and the volume reduction of the implants. The uncoated 
magnesium alloy showed the least volume of new bone growth of 1.36mm3 and the 
largest volume reduction of 0.33% after 2 months of implantation (Figure 15a). 
Among the polymer sprayed samples, HPM had also corroded, however, had a 
smaller implant volume reduction (0.05%) and more bone formation (5.17mm3) than 
the uncoated sample. The LMP sample had the greatest amount of new bone 
formation of 10.79mm3 and did not have any implant volume reduction. 
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3.6.3 Serum magnesium measurements 
Figure 16 shows the changes in the serum magnesium levels of all the implants 
after 2 months post-operation. The serum magnesium levels of all the rabbits were 
noted to fluctuate from approximately 13ppm to 19ppm. No trend could be 
determined from the results. 
 
3.6.4 Histological evaluation 
Figure 17 shows the tissue response to both polymer-coated and uncoated 
magnesium alloy after 2 months of implantation, where new bone tissue (black arrows) 
was observed to form around the implant. All the samples showed direct contact with 
the newly formed bone. Osteoblasts, which are responsible for new bone formation, 
were also observed around the implants (green arrows). More bone was formed 
around the polymer-coated implants in comparison to the un-coated sample. 
 
4 Discussion 
The use of magnesium alloys as biodegradable materials was first investigated 
during the first half of the last century [28, 29]. The major obstacles of applying 
magnesium alloys in clinical use are its rapid degradation rate and the release of 
hydrogen gas upon degradation. Hence, different modifications of magnesium alloys 
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have been conducted, of which one of the approaches is surface modification [12, 17, 
18, 30-32]. By conducting a suitable surface modification, the corrosion resistance 
properties of magnesium alloys may be enhanced. 
In this study, we constructed degradable polymeric membranes with controllable 
porosity and deposited these onto the magnesium alloys. The pore formation was 
mainly due to the process of phase separation [33, 34] in which the solvent 
evaporation in the polymer solution acted as a driving force for phase separation since 
the polymer solution became thermodynamically unstable during solvent evaporation. 
This resulted in the formation of either a polymer-rich or polymer-poor phase [35-37], 
where the polymer-rich phase would be solidified, whereas the polymer-poor phase 
led to pore formation. Moreover, the size of the pores was related to the concentration 
of the polymer solution, where a more concentrated polymer solution resulted in 
smaller pores due to the presence of less polymer-poor phase [38, 39], and this 
explains why larger pores were observed on the HPM as compared to the LPM. In 
addition, the polymer membrane was deposited layer-by-layer with smaller pores in 
the inner layer which was mainly due to the amount of polymer present in each layer. 
We assumed that part of the outer layer of polymer would merge into the pores of the 
inner layer which would result in the pores being filled up, however, as it is 
impossible to completely fill these, smaller pores were therefore observed in the inner 
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layer. As a result of this, lower amounts of polymer were present in the outer layer 
which led to the formation of larger pores in the outer layer. Further studies to verify 
this are currently in progress. 
The compressive strengths of both the coated and uncoated samples at the 0 hour 
time point were found to be similar since the polymer membrane did not affect the 
bulk mechanical properties of the magnesium alloy. Whilst the compressive strength 
of the uncoated sample dropped significantly due to corrosion and magnesium ion 
release during the early time points, the rate of decrease in the compressive strength 
was reduced at later time points due to magnesium hydroxide formation [40]. 
However, the compressive strengths of the polymer-coated samples remained at least 
60MPa higher than the uncoated samples after two months of immersion, which was 
largely due to the slower corrosion rate of the implant. This is a critical factor to 
consider for the application of polymer-based membranes in orthopaedic implants. 
The mechanical integrity of an orthopaedic implant is very important since it is used 
to fix fractured bones, therefore, the implant must provide enough mechanical support 
to the bone throughout the healing process. Since the strength of an uncoated implant 
decreased more than 50% in two months due to corrosion, the slower rate of corrosion 
of the polymer-coated implants, which were still maintained at above 70%, would 
thus suit the application of orthopaedic implants as the strength of the implant is 
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maintained within the first two months which would allow for a longer period of time 
for bone fractures to heal. However, further long-term studies are needed to confirm 
this. 
From the radiographs, no gas bubbles were observed throughout the entire 
experimental period for both polymer-coated and uncoated samples, which was 
different from other studies [5, 12]. Witte et al. [12] reported that the implantation of 
AZ91 magnesium alloy into guinea pig femora intramedullary resulted in gas bubbles 
appearing within one week of implantation and subsequently disappearing after two to 
three weeks, whereas in another study, the appearance of gas bubbles occurred during 
the first month [5]. The difference between this study and Witte’s study may be 
explained by a number of reasons including the different animal model used, the size 
of the implant, and the implantation site. Although we used the same type of AZ91 
magnesium alloy, the sample that Witte et al. (2005) used had a surface-to-volume 
ratio approximately 1.65 times larger than the one used in our study, which would 
have resulted in a large surface area exposed to the body, thereby increasing the 
amount of corrosion of the implant. This could have resulted in a hydrogen gas 
release rate that was faster than the absorption rate, which may explain why hydrogen 
gas was observed during the first three weeks after implantation. Over time, the 
corrosion rate would have slowed down because of the formation of magnesium 
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hydroxide [12], and thus the gas would have been absorbed afterwards, which 
accounts for the disappearance of the hydrogen gas bubbles after two to three weeks 
[5].  
In order to visualize the corrosion morphology and quantify the in-vivo corrosion 
rate, micro-computed tomography was employed. Under in-vivo conditions, slight 
corrosion occurred on HPM but not on the LPM, which correlated with the in-vitro 
data. Since increased numbers of pores, and larger pore size were found on the HPM, 
this allowed more body fluid to pass through and make contact, therefore increasing 
the amounts of corrosion of the HPM in comparison to the LPM. Nonetheless the 
uncoated implant still corroded the fastest out of the three types of samples. This 
indicated that the polymer membrane was able to reduce the release of magnesium 
ions, thereby controlling the degradation rate of magnesium alloy in the in-vivo 
environment.  
Bone formation was studied and quantified using micro-computed tomography. 
The newly formed bone was found around the implants of both coated and uncoated 
samples and there were no adverse effects were found after implantation, which 
proved their biocompatibility. Although corrosion occurred on uncoated and HPM 
samples, bone formation was still observed around those implants, which concur with 
others’ findings [5, 7]. However, upon comparison of the amount of new bone 
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formation, it was found that the uncoated sample had the least amount of new bone 
formation and the polymer-coated samples had the new bone volume in descending 
order of LPM > HPM. Higher amounts of bone formation around the polymer-coated 
samples as compared to the uncoated samples may be due to several reasons. One 
reason for this may be attributed to a reduced rate of corrosion, as the polymer coating 
decreased the amount of direct contact with the body. In addition, large amounts of 
magnesium ion release during corrosion of the uncoated sample possibly inactivated 
new bone formation [41], thereby resulting in less new bone formation around the 
uncoated sample when compared to the polymer-coated samples. The high levels of 
new bone formation found on the LPM sample may be explained by the release of 
low levels of magnesium ions, which has been reported to enhance osteoblastic 
activity and thus generate a stimulatory effect on the growth of new bone tissue [1, 
42], and also correlated with the MTT data in this study. Hence, LPM-coated samples 
may have induced more new bone formation due to the release of low levels of 
magnesium ions. 
Histological analysis revealed an area of bone formation around the implants and 
although corrosion was found on uncoated and HPM samples in the histological 
staining, which was confirmed with micro-CT analysis, there was an absence of 
inflammation and necrosis, which suggested that there were no toxic effects in the 
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surrounding tissues. This was a good indication that the coated sample would be safe 
for in-vivo use, considering that once the polymer membrane degraded, the un-coated 
magnesium alloy would also degrade and not induce adverse effects into the localized 
tissues. This correlated with the serum magnesium measurements where no 
significant differences were observed between the serum magnesium levels after 
implantation for either the coated or uncoated samples, which most likely due to 
homeostatic regulation by the kidney [12, 43]. The detected serum magnesium ion 
levels were below 20 ppm and were within the normal range of physiological 
magnesium levels [43-46]. Correlating the observed serum magnesium levels with the 
MTT assay data, a toxic effect occurred only if the magnesium ion concentration 
exceeded 150 ppm, which indicated that there should be no toxicity problems 
occurring in-vivo. Taking this data together, the polymer-coated samples reduces the 
rate of magnesium ion release and allows for the homeostatic maintenance of 
physiological magnesium levels. More importantly, the data indicates that after the 
polymer-coating is degraded, thus leaving behind the uncoated implant, the release of 
magnesium ions from this uncoated implant does not induce toxic levels of 
magnesium. Further long-term in-vivo studies, which continue until complete 
degradation of the implant, are needed to verify this. 
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4.2 Conclusion 
In summary, this study demonstrated the effectiveness of applying a porosity 
controllable biodegradable polymer membrane on a magnesium alloy. The addition of 
a polymer-coating on the implant was shown to reduce the corrosion rate of the 
implant. This was mainly related to the pore size of the membrane, which may be 
altered during synthesis to suit potential applications. In addition to reducing the 
corrosion rate of the magnesium alloy, the polymer-coated samples also aided in 
retaining the mechanical strength of the implant in contrast to uncoated samples 
during the immersion test. This is a great advantage for the application of polymer-
coated implants for orthopaedic procedures as the slower release rate of magnesium 
ions and strength of the polymer-coated implants allows for sufficient time for bone 
healing and also promotes new bone growth. Our study also indicated good cell 
biocompatibility with no observed inflammation or necrosis. Additionally, the serum 
magnesium levels after implantation were retained within a normal physiological 
range. This was also observed for the uncoated samples, which indicated that after 
degradation of the polymer coating from the implant, further corrosion of the implant 
would not result in cell toxicity. Further studies are needed to improve the 
membrane’s adhesion properties to the implant and additional long-term in-vivo 
studies are required to further validate the use of polymer-coated implants for 
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orthopaedic implants.  
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Figure captions 
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Figure 1 Uncoated and PCL-coated sample rods implantation in greater trochanter of New Zealand 
White rabbit for 2 months. (a) Uncoated, (b) LPM and (c) HPM 
Figure 2 Surface morphology of the polymer membranes under scanning electron microscopy (SEM). (a) 
LPM, (b) HPM 
Figure 3a Characterization of the pores formed on the LPM using CTAn software 
Figure 3b Characterization of the pores formed on the HPM using CTAn software 
Figure 4 Heating and cooling scans of DSC thermograms of different PCL membranes. Tm represents 
the melting temperature while Tc represents the crystallization temperature 
Figure 5 Potentiodynamic polarization curves of PCL coated and uncoated magnesium alloys which was 
obtained from the electrochemical measurement. The polarization scan started from -220mV at a scan 
rate of 1mV/s and the changes in the free corrosion potential (E ) were monitored as a function of timecorr
Figure 6 Magnesium ions released from PCL-coated and uncoated AZ91 magnesium alloy over time as 
measured by inductively coupled plasma mass spectrometry (ICPMS). All the values of both the LPM 
and HPM samples were found to be significantly different (p < 0.05) when compared with the uncoated 
sample 
Figure 7 pH values of PCL-coated and uncoated AZ91 magnesium alloy over time. All the values of both 
the LPM and HPM samples were found to be significantly different (p < 0.05) when compared with the 
uncoated sample 
Figure 8 Total weight lost from PCL-coated and uncoated AZ91 magnesium over time 
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Figure 9 Cell viability of PCL-coated and uncoated AZ91 magnesium alloy over time as derived from the 
absorbance reading at 570nm wavelength using the MTT assay. The reference wavelength of 640nm 
was used to determine the cell viability in comparison to the control 
Figure 10 Correlation between cell viability and the magnesium ion concentration of PCL-coated and 
uncoated AZ91 magnesium alloy. (a) PCL-coated, (b) Uncoated samples 
Figure 11 Microscopic views of GFP mouse osteoblasts cultured on PCL-coated and uncoated AZ91 
magnesium alloy after 1 and 3 days. (a) 1 day; (b) 3 days. 5,000 GFPOB were cultured on the coated 
and uncoated samples for 1 and 3 days so as to evaluate the cyto-compatibility of the polymer-coated 
magnesium alloys.                                                                                                                                                                             
Figure 12 Compressive strength of PCL-coated and uncoated AZ91 magnesium alloy over time. The 
compression test was conducted by using the Material Testing System (MTS) with the testing speed 
0.45 m/m.min
Figure 13 Radiographs of PCL-coated and uncoated AZ91 magnesium alloy after 1 week, 1 and 2 
months post-operation. (a to c) uncoated, LPM, and HPM after 1 week post-operation, respectively; (d to 
f) uncoated, LPM and HPM after 1 month post-operation, respectively; (g to i) uncoated, LPM and HPM 
after 2 months post-operation, respectively 
Figure 14 Micro-CT reconstruction images of the greater trochanter containing coated and uncoated 
sample. (a to c) transverse view; (d to f) coronal view and (g to i) 3D view of the uncoated, LPM and 
HPM samples. The corrosion condition of the samples can be scanned and viewed in a micro-computed 
 
 
 
tomography device 
Figure 15 Micro-CT 3D reconstruction models of newly formed bone (white in color) on both coated and 
uncoated implants. (a) Uncoated, (b) LPM and (c) HPM 
Figure 16 Changes in serum magnesium levels before and after implantation. The serum was collected 
by centrifugation at 1,339 g for 15 mins at room temperature. The magnesium ion concentration was 
determined by inductively-coupled plasma mass spectrometry (ICPMS) 
Figure 17 Histological photographs of gimesa stained of the bone tissue formed around the implant after 
2 months’ implantation in the greater trochanter where arrows represent the newly formed bone and 
circles represent the presence of osteoblasts. (a) Uncoated, (b) LPM and (c) HPM 
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Figure 2 
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Figure 8 
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Figure 14  
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Figure 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
b  c
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
Figure 16 
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Table 1. Thermal properties of different PCL membranes determined by differential 
scanning calorimetry  
Sample Tm (℃) Tc (℃) ∆Hm (J/g) Xc (%) 
PCL only 61.24 18.15 49.87 35.9 
LPM 57.29 28.58 54.36 39.1 
HPM 56.20 29.03 57.36 41.3 
Tm represents the melting temperature; Tc represents the crystallization temperature; 
∆Hm represents the change of melting of heat and Xc represents the crystallinity 
 
 
 
 
Table 2. Amounts of new bone volume and the remaining implant volume after 2 
months implantation 
Sample New bone 
volume (mm3) 
Initial implant 
volume (mm3) 
Final implant 
volume (mm3) 
Implant volume 
change (%) 
Uncoated 1.36 42.41 42.27 -0.33 
LPM 10.79 42.41 42.41 0 
HPM 5.17 42.41 42.39 -0.05 
 
 
 
 
